Tenet Healthcare (NYSE:THC) EVP Paola Arbour Sells 10,878 Shares

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 10,878 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the completion of the transaction, the executive vice president owned 18,413 shares of the company’s stock, valued at $4,490,930.70. This represents a 37.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $262.36 on Wednesday. The company has a market capitalization of $22.60 billion, a P/E ratio of 10.12, a price-to-earnings-growth ratio of 1.37 and a beta of 1.27. Tenet Healthcare Corporation has a 52 week low of $155.02 and a 52 week high of $262.68. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company’s 50 day moving average price is $187.59 and its two-hundred day moving average price is $198.22.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the prior year, the firm earned $4.02 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, analysts expect that Tenet Healthcare Corporation will post 20.9 earnings per share for the current fiscal year.

Institutional Trading of Tenet Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of THC. Triumph Capital Management acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management acquired a new stake in shares of Tenet Healthcare in the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare during the fourth quarter worth $29,000. Meeder Asset Management Inc. raised its position in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at $35,000. Institutional investors own 95.44% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on THC. Stephens restated an “overweight” rating and issued a $285.00 price target on shares of Tenet Healthcare in a report on Monday. Royal Bank Of Canada increased their price objective on Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a report on Monday. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Monday. Raymond James Financial set a $270.00 price target on shares of Tenet Healthcare in a research note on Monday. Finally, UBS Group lifted their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $268.50.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong Q2 results and improved outlook: Tenet beat analyst expectations for both earnings and revenue, while raising its 2026 forecast. Performance was driven by solid same-facility growth and disciplined expense management, reinforcing the company’s operating momentum. Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook
• Positive Sentiment: Analysts raise price targets: Truist increased its target to $290 from $270 and maintained a “buy” rating. Guggenheim raised its target to $283 from $242 and also rated the shares “buy.” The upgrades suggest analysts see further upside following the earnings beat and improved guidance. Analyst price-target updates
• Positive Sentiment: Growth-stock appeal: Zacks highlighted Tenet as a highly ranked growth stock, which could attract additional interest from growth, value and momentum-focused investors. Tenet Healthcare Is a Top-Ranked Growth Stock
• Neutral Sentiment: Mixed analyst signal: Robert W. Baird lifted its target sharply to $280 from $210 but retained a “neutral” rating, indicating improved valuation expectations without a full shift to a bullish stance. Analyst price-target update
• Negative Sentiment: Executive and director stock sales: EVP Paola M. Arbour sold 10,878 shares worth approximately $2.65 million, reducing her position by 37.14%. Director Christopher S. Lynch sold 3,837 shares worth about $934,000, cutting his ownership by 28.62%. Although these sales may be for personal or tax-related reasons, the sizable transactions could create a modest overhang for THC. Tenet Healthcare insider transaction filing

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.